Shots:

• Eli Lilly collaborates with DexCom- Glooko- myDiabby Healthcare and Roche to integrate the data and technology into connected insulin pen solutions and provide streamlined care for diabetes patients in markets outside the US
• The 4 companies will provide diabetes management platforms that are well-suited with Lilly’s Tempo Pen and Tempo Smart Button to help streamline diabetes management through automated data collection for insulin dose tracking
• Lilly plans to receive a CE mark for the Tempo Smart Button later in 2021 and will launch the Tempo Pen and Tempo Smart Button in various global markets following the approval

  Ref: PRNewswire | Image: Eli Lilly